The keynote address at the 2022 American Society of Clinical Oncology (ASCO) meeting earlier in June was met with great enthusiasm. André Ilbawi, WHO’s Cancer Control Officer, announced the first partnership between ASCO and WHO that, he says, “catalyses meaningful innovation to address persistent inequities—locally and globally—in cancer care”.
